nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
(A6) Aplastic anaemia (AA) or hypoplastic MDS?
|
Geary, C.G. |
|
1991 |
15 |
S |
p. 1- 1 p. |
artikel |
2 |
Abnormal multimeric pattern of platelet von willebrand factor (Plt vWF) in myelodysplastic syndromes (MDS)
|
|
|
1991 |
15 |
S |
p. 30- 1 p. |
artikel |
3 |
Acanthocytosis (spur cells) in disparate clinical states — myelodysplasia and alzheimer's disease
|
Goodall, H.B. |
|
1991 |
15 |
S |
p. 19- 1 p. |
artikel |
4 |
A case of pre-myelodysplasia
|
|
|
1991 |
15 |
S |
p. 23- 1 p. |
artikel |
5 |
(A4) Chronic myelomonocytic leukemia (CMML)
|
Pierre, Robert V. |
|
1991 |
15 |
S |
p. 1- 1 p. |
artikel |
6 |
(A5) Chronic neutrophilic leukemia with dysplastic features (CNL-D). A report of seven patients
|
Symeonidis, A. |
|
1991 |
15 |
S |
p. 1- 1 p. |
artikel |
7 |
(A1) Definition and classification of the myelodysplastic syndromes (MDS)
|
|
|
1991 |
15 |
S |
p. 1- 1 p. |
artikel |
8 |
(A9) Dysplastic changes of peripheral blood polymorphs in elderly de novo AML patients — sign of a link to MDS?
|
Hast, R |
|
1991 |
15 |
S |
p. 2- 1 p. |
artikel |
9 |
(A8) Heterogeneity of acquired idiopathic sideroblastic anaemia (AISA)
|
Garand, R. |
|
1991 |
15 |
S |
p. 2- 1 p. |
artikel |
10 |
A method for the prediction of the clinical course of MDS
|
Ryausova, L.Y. |
|
1991 |
15 |
S |
p. 16- 1 p. |
artikel |
11 |
(A7) Myelodysplastic syndromes with bone marrow fibrosis: A myelodysplastic disorder with proliferative features
|
|
|
1991 |
15 |
S |
p. 2- 1 p. |
artikel |
12 |
Analysis of 36 cases of secondary myelodysplastic syndrome
|
|
|
1991 |
15 |
S |
p. 20- 1 p. |
artikel |
13 |
Assessment of cell proliferation in primary myelodysplastic syndromes
|
|
|
1991 |
15 |
S |
p. 29- 1 p. |
artikel |
14 |
Assessment of clonality in females heterozygous at the DXS255 locus
|
|
|
1991 |
15 |
S |
p. 25- 1 p. |
artikel |
15 |
Author index
|
|
|
1991 |
15 |
S |
p. I-IV nvt p. |
artikel |
16 |
(B8) Case control study of occupational and environmental exposure and myelodysplasia
|
West, Robert |
|
1991 |
15 |
S |
p. 4- 1 p. |
artikel |
17 |
(B9) Childhood MDS in Turkey — clinical experience in 25 cases
|
Tuncer, A.M. |
|
1991 |
15 |
S |
p. 5- 1 p. |
artikel |
18 |
(B1) Epidemiology of myelodysplastic syndrome
|
|
|
1991 |
15 |
S |
p. 3- 1 p. |
artikel |
19 |
(B7) Establishing the incidence of MDS-population surveys
|
Williamson, P.J. |
|
1991 |
15 |
S |
p. 4- 1 p. |
artikel |
20 |
(B6) MDS during medical surveillance of a refinary population
|
Cowles, S.R. |
|
1991 |
15 |
S |
p. 4- 1 p. |
artikel |
21 |
(B4) Myelodysplastic syndromes and leukemias in atomic bomb survivors
|
Tomonaga, Masao |
|
1991 |
15 |
S |
p. 3- 1 p. |
artikel |
22 |
Bone marrow transplantation (BMT) for myelodysplasia (MDS): alternative preparation with busulfan/cyclophosphamide (BU/CY)
|
O'Donnell, M.R. |
|
1991 |
15 |
S |
p. 31- 1 p. |
artikel |
23 |
(B3) Organic solvents in leukaemogenesis
|
Brandt, L. |
|
1991 |
15 |
S |
p. 3- 1 p. |
artikel |
24 |
(B5) Results from a semi-national registry of MDS cases in England and Wales
|
Alexander, F.E. |
|
1991 |
15 |
S |
p. 4- 1 p. |
artikel |
25 |
(B2) Treatment induced myelodysplasia (t-MDS)
|
|
|
1991 |
15 |
S |
p. 3- 1 p. |
artikel |
26 |
(C7) Alterations in the p53 gene in primary myelodysplastic syndrome (pMDS)
|
|
|
1991 |
15 |
S |
p. 6- 1 p. |
artikel |
27 |
(C3) Chromosomal deletions in haematological malignancies
|
Hirst, W.J.R. |
|
1991 |
15 |
S |
p. 6- 1 p. |
artikel |
28 |
(C11) Clonality of hematopoiesis in patients with aplastic anemia and myelodysplastic syndromes
|
van Kamp, H. |
|
1991 |
15 |
S |
p. 7- 1 p. |
artikel |
29 |
(C1) Cytogenetics of MDS
|
Mecucci, Cristina |
|
1991 |
15 |
S |
p. 5- 1 p. |
artikel |
30 |
(C9) Direct sequencing of C-FMS in myelodysplastic syndrome and AML
|
|
|
1991 |
15 |
S |
p. 7- 1 p. |
artikel |
31 |
Changes of purine metabolism in RBCS from patients with myelodysplastic syndromes
|
|
|
1991 |
15 |
S |
p. 30- 1 p. |
artikel |
32 |
Chromosome analyses of colonies in myelodysplastic syndrome
|
Högh-Kristiansen, Inge |
|
1991 |
15 |
S |
p. 23- 1 p. |
artikel |
33 |
(C2) Implications of chromosome 5 involvment
|
Le Beau, Michelle M. |
|
1991 |
15 |
S |
p. 5- 1 p. |
artikel |
34 |
Classification of the myelodysplastic syndromes (MDS): Criteria for their histologic recognition
|
Frisch, Bertha |
|
1991 |
15 |
S |
p. 15- 1 p. |
artikel |
35 |
Clonal chromosome abnormalities identify myelodysplastic syndrome (MDS) complicating hairy cell leukemia (HCL)
|
|
|
1991 |
15 |
S |
p. 23- 1 p. |
artikel |
36 |
Clonal development (MDS) in aplastic anemia (AA) patients with long-term survival
|
Castro-Malaspina, H |
|
1991 |
15 |
S |
p. 25- 1 p. |
artikel |
37 |
(C8) Microdeletion of CSFIR in myelodysplasia
|
Boultwood, J |
|
1991 |
15 |
S |
p. 7- 1 p. |
artikel |
38 |
(C4) Molecular pathology of MDS
|
Padua, R.A. |
|
1991 |
15 |
S |
p. 6- 1 p. |
artikel |
39 |
(C6) Mutations of the P53 gene in myelodysplastic syndromes (MDS). A report on 152 cases
|
Fenaux, P. |
|
1991 |
15 |
S |
p. 6- 1 p. |
artikel |
40 |
Comparative studies of SCE in peripheral lymphocytes from patients with myelodysp lastic syndromes and aplastic anemia
|
Xi-Jian, Wang |
|
1991 |
15 |
S |
p. 24- 1 p. |
artikel |
41 |
(C10) Studies of clonality in patients with refractory anaemia and chromosome deletions
|
Abrahamson, G |
|
1991 |
15 |
S |
p. 7- 1 p. |
artikel |
42 |
Cyclic haemopoiesis in association with familial refractory anaemia
|
Bowen, D.T. |
|
1991 |
15 |
S |
p. 29- 1 p. |
artikel |
43 |
Cytogenetical findings in refractory anemia with ring sideroblasts (RARS)
|
Shtalrid, M. |
|
1991 |
15 |
S |
p. 22- 1 p. |
artikel |
44 |
Cytogenetic observations in myelodysplastic syndromes (MDS) before and after GM-CSF
|
Jacobson, R.J. |
|
1991 |
15 |
S |
p. 23- 1 p. |
artikel |
45 |
Cytogenetic study of MDS evolving to AML
|
Musilova, J. |
|
1991 |
15 |
S |
p. 21- 1 p. |
artikel |
46 |
Data on 700 MDS patients in Czechoslovakia
|
|
|
1991 |
15 |
S |
p. 16- 1 p. |
artikel |
47 |
(D11) Cytokine regulation of megakaryopoiesis in patients with myelodysplastic syndrome (MDS)
|
|
|
1991 |
15 |
S |
p. 10- 1 p. |
artikel |
48 |
(D9) Differentiation of blast cells in MDS and acute myeloid leukemia by automated image analysis
|
|
|
1991 |
15 |
S |
p. 9- 1 p. |
artikel |
49 |
(D2) Differentiation therapy in myelodysplastic syndrome
|
|
|
1991 |
15 |
S |
p. 8- 1 p. |
artikel |
50 |
Defective autologous and allogeneic mixed lymphocyte reaction (MLR) in patients with primary myelodysplastic syndromes (MDS)
|
Symeonidis, A. |
|
1991 |
15 |
S |
p. 29- 1 p. |
artikel |
51 |
Deletions and gene polymorphisms of 5q located genes in 12 pat with myeloid leukemias
|
|
|
1991 |
15 |
S |
p. 24- 1 p. |
artikel |
52 |
Desferrioxamine treatment reduces blood transfusion requirements in patients with myelodysplastic syndrome
|
Jensen, P-D. |
|
1991 |
15 |
S |
p. 33- 1 p. |
artikel |
53 |
Determination of clonality in myelodysplasia by polymerase chain reaction
|
van Kamp, H. |
|
1991 |
15 |
S |
p. 25- 1 p. |
artikel |
54 |
(D4) Expression of the multidrug resistance ( MDR 1) gene in MDS
|
|
|
1991 |
15 |
S |
p. 8- 1 p. |
artikel |
55 |
(D3) Growth factor receptors
|
|
|
1991 |
15 |
S |
p. 8- 1 p. |
artikel |
56 |
(D5) Haemopoiesis in long-term marrow culture as an indicator of early myelodysplasia
|
McMullin, M.F. |
|
1991 |
15 |
S |
p. 8- 1 p. |
artikel |
57 |
Diagnosis of clonality of myelodysplastic syndromes (MDS) by polymerase chain reaction (PCR) of phosphoglycerate kinase (PGK) gene
|
|
|
1991 |
15 |
S |
p. 24- 1 p. |
artikel |
58 |
Differential diagnosis of myelodysplasia (MDS) and erythroleukemia (FAB:M6). A multicenter I.G.C.I. trial
|
|
|
1991 |
15 |
S |
p. 19- 1 p. |
artikel |
59 |
(D6) IL-3 plus IL-6 improve hematopoiesis in long-term bone marrow cultures (LTBMC) of patients with myelodysplastic syndromes (MDS)
|
Kourakli, A. |
|
1991 |
15 |
S |
p. 9- 1 p. |
artikel |
60 |
(D7) Increased circulating CD34+ cells in myelodysplastic syndromes: An adverse prognostic feature
|
Marsden, K.A. |
|
1991 |
15 |
S |
p. 9- 1 p. |
artikel |
61 |
Disturbances of haemopoietic organisation and maturation in myelodysplastic syndromes demonstrated by differential staining with immunohistochemical markers
|
Wilkins, B.S. |
|
1991 |
15 |
S |
p. 15- 1 p. |
artikel |
62 |
(D10) MDS marrow macrophages inhibit granulocyte-macrophage progenitors from normal marrow
|
Yoshida, Y. |
|
1991 |
15 |
S |
p. 10- 1 p. |
artikel |
63 |
(D8) Multiparameter flow cytometry in patients with myelodysplastic syndromes
|
Jensen, Inger Marie |
|
1991 |
15 |
S |
p. 9- 1 p. |
artikel |
64 |
(E9) BMT for MDS
|
|
|
1991 |
15 |
S |
p. 12- 1 p. |
artikel |
65 |
(E8) Effectiveness of attenuated chemotherapy in the treatment of myelodysplasia
|
|
|
1991 |
15 |
S |
p. 11- 1 p. |
artikel |
66 |
(E3) Has survival improved in the past ten years?
|
Reynolds, Paul |
|
1991 |
15 |
S |
p. 11- 1 p. |
artikel |
67 |
(E7) Intensive chemotherapy in MDS
|
|
|
1991 |
15 |
S |
p. 11- 1 p. |
artikel |
68 |
(E6) Involvement of RAR-α in the RA inducible regulation of myeloid cell differentiation
|
Hardas, B.D. |
|
1991 |
15 |
S |
p. 11- 1 p. |
artikel |
69 |
Electron microscopic observations on bone marrow: A study of 50 myelodysplastic syndromes (MDS)
|
Irriguible, D. |
|
1991 |
15 |
S |
p. 20- 1 p. |
artikel |
70 |
(E2) Long-term survivors of the myelodysplastic syndromes
|
Oguma, S. |
|
1991 |
15 |
S |
p. 10- 1 p. |
artikel |
71 |
(E11) Myelodisplastic syndrome (MDS) and secondary leukaemia (SEC-AL) treated by allogeneic BMT: a retrospective analysis from GITMO
|
|
|
1991 |
15 |
S |
p. 12- 1 p. |
artikel |
72 |
(E1) Natural history of myelodysplastic syndromes
|
Sanz, Guillermo F |
|
1991 |
15 |
S |
p. 10- 1 p. |
artikel |
73 |
Factors other than Hb concentration influencing serum EPO levels in patients with MDSs
|
|
|
1991 |
15 |
S |
p. 30- 1 p. |
artikel |
74 |
Familial MDS
|
Douglas, A. |
|
1991 |
15 |
S |
p. 22- 1 p. |
artikel |
75 |
(F5) A phase I–II trial of erythropoietin [epoetin-β] (EPO) in patients with myelodysplastic syndromes (MDS)
|
Stone, R. |
|
1991 |
15 |
S |
p. 13- 1 p. |
artikel |
76 |
(F9) A phase I trial of recombinant human interleukin-3 (rhIL-3) in patients with myelodysplastic syndrome (MDS) and aplastic anemia (AA)
|
|
|
1991 |
15 |
S |
p. 14- 1 p. |
artikel |
77 |
(F3) Efficacy and safety of recombinant human erythropoietin (r-HuEPO) in anemic patients with myelodysplastic syndromes
|
|
|
1991 |
15 |
S |
p. 13- 1 p. |
artikel |
78 |
(F1) GM-CSF and IL-3 in the treatment of MDS
|
Ganser, A. |
|
1991 |
15 |
S |
p. 12- 1 p. |
artikel |
79 |
(F8) GM-CSF treatment in myelodysplastic syndromes: Results of a multicenter randomized controlled study
|
|
|
1991 |
15 |
S |
p. 14- 1 p. |
artikel |
80 |
(F2) Granulocyte colony-stimulating factor (G-CSF) in the treatment of myelodysplastic syndromes (MDS)
|
Greenberg, P. |
|
1991 |
15 |
S |
p. 12- 1 p. |
artikel |
81 |
(F7) Randomized phase II study with GM-CSF and low-dose ARAC in patients with “high risk” myelodysplastic syndromes
|
|
|
1991 |
15 |
S |
p. 14- 1 p. |
artikel |
82 |
(F4) Treatment of high risk myelodysplastic syndromes with sequential intermediate dose cytosine arabinoside and mitoxantrone (S-HAM) with or without GM-CSF: A prospective double blinded randomised study
|
Hiddemann, W |
|
1991 |
15 |
S |
p. 13- 1 p. |
artikel |
83 |
(F6) Treatment of myelodysplastic syndromes with erythropoietin and granulocyte-CSF in combination
|
|
|
1991 |
15 |
S |
p. 13- 1 p. |
artikel |
84 |
Functional relevance of differentiation of AML blasts with GM-CSF and 1,25-dihydroxy-vitamin D3 (D3)
|
Kelsey, S.M. |
|
1991 |
15 |
S |
p. 31- 1 p. |
artikel |
85 |
G-CSF and GM-CSF expression and paracrine/autocrine growth mechanisms in P-MDS
|
|
|
1991 |
15 |
S |
p. 28- 1 p. |
artikel |
86 |
(G1) The past, the present and the future
|
Hamblin, Terry |
|
1991 |
15 |
S |
p. 14- 1 p. |
artikel |
87 |
Haematological, radiological and biological studies in myelodisplastic syndromes (MDS)
|
|
|
1991 |
15 |
S |
p. 15- 1 p. |
artikel |
88 |
Haematologic and biochemical parameters are strong prognostic indicators in chronic myelomonocytic leukaemia (CMML): A multivariate analysis of prognostic factors in 93 cases
|
|
|
1991 |
15 |
S |
p. 17- 1 p. |
artikel |
89 |
Iliac bone marrow findings and prognosis in MDS patients
|
|
|
1991 |
15 |
S |
p. 15- 1 p. |
artikel |
90 |
IL-2R: A prognostic factor for MDS patients
|
|
|
1991 |
15 |
S |
p. 26- 1 p. |
artikel |
91 |
IL-6 serum concentrations in patients with MDS
|
Herold, M. |
|
1991 |
15 |
S |
p. 27- 1 p. |
artikel |
92 |
Immunophenotypic and clinical characteristics of acute leukemia following a myelodysplastic syndrome
|
|
|
1991 |
15 |
S |
p. 26- 1 p. |
artikel |
93 |
Influence of IL-8 on granulo-monocytic progenitor cell (CFU-GM) growth in normal persons and MDS patients
|
|
|
1991 |
15 |
S |
p. 28- 1 p. |
artikel |
94 |
In vitro patterns and morphology of myelodysplastic bone marrow in relation to patient prognosis
|
|
|
1991 |
15 |
S |
p. 27- 1 p. |
artikel |
95 |
In vivo induction of soluble IL-2R expression in MDS patients under treatment with IL-3
|
|
|
1991 |
15 |
S |
p. 27- 1 p. |
artikel |
96 |
Isolated thrombocytopenia as the sole initial manifestation of myelodysplasia
|
Beris, Ph. |
|
1991 |
15 |
S |
p. 19- 1 p. |
artikel |
97 |
6-Merkaptopurin in the treatment of CMML
|
|
|
1991 |
15 |
S |
p. 32- 1 p. |
artikel |
98 |
Molecular genetic evidence for clonal proliferation in MDS
|
Morita, K. |
|
1991 |
15 |
S |
p. 24- 1 p. |
artikel |
99 |
Monitoring of bone marrow CFU-GM in myelodysplastic syndromes
|
|
|
1991 |
15 |
S |
p. 27- 1 p. |
artikel |
100 |
Morphologic and prognostic significance of karyotype abnormalities in de novo myelodysplastic syndromes (MDS)
|
|
|
1991 |
15 |
S |
p. 21- 1 p. |
artikel |
101 |
Myelodysplastic syndrome associated with chronic lymphocytic leukaemia: A report of three cases
|
Vallespí, T. |
|
1991 |
15 |
S |
p. 20- 1 p. |
artikel |
102 |
Myelodysplastic syndromes: Cytogenetic studies of 130 cases
|
Donti, E. |
|
1991 |
15 |
S |
p. 21- 1 p. |
artikel |
103 |
Neutralization of leukocyte-derived inhibitory activity produced by MDS patients with monoclonal antibody against H-subunit-rich ferritin
|
|
|
1991 |
15 |
S |
p. 30- 1 p. |
artikel |
104 |
Phase I trial of amonafide (AM) for poor prognosis acute leukemias
|
|
|
1991 |
15 |
S |
p. 32- 1 p. |
artikel |
105 |
Prognostic assessment of the myelodysplastic syndromes (MDS). Validity of a simple scoring system for clinical usage
|
|
|
1991 |
15 |
S |
p. 17- 1 p. |
artikel |
106 |
Prognostic factors in MDS: A mathematical model
|
Montillo, M. |
|
1991 |
15 |
S |
p. 16- 1 p. |
artikel |
107 |
Prognostic significance of bone marrow CFU-GM and cytogenetic studies in primary myelodisplastic syndromes (MDS)
|
|
|
1991 |
15 |
S |
p. 28- 1 p. |
artikel |
108 |
Prognostic value of chromosome analysis in myelodysplastic syndromes
|
Torrabadella, M. |
|
1991 |
15 |
S |
p. 21- 1 p. |
artikel |
109 |
Promising results in MDS-AML after combination treatment with GM-CSF and chemotherapy
|
Bernell, Per |
|
1991 |
15 |
S |
p. 34- 1 p. |
artikel |
110 |
5q deletion in MDS. Prognostic value of additional cytogenetic changes and “typical” dysmegakaryopoiesis (dysMK)
|
|
|
1991 |
15 |
S |
p. 18- 1 p. |
artikel |
111 |
Recombinant human erythropoietin for the treatment of anaemia in the myelodysplastic syndromes
|
|
|
1991 |
15 |
S |
p. 33- 1 p. |
artikel |
112 |
Recombinant human erythropoietin for the treatment of anaemia in the myelodysplastic syndromes
|
|
|
1991 |
15 |
S |
p. 22- 1 p. |
artikel |
113 |
Recombinant human erythropoietin (rh Epo): A possible treatment for the anemia of myelodysplastic syndromes (MDS)
|
Ismard, F. |
|
1991 |
15 |
S |
p. 32- 1 p. |
artikel |
114 |
Refractory anaemia with ring sideroblasts (RAS): A simple scoring system based on easily available parameters
|
Vallespí, T. |
|
1991 |
15 |
S |
p. 18- 1 p. |
artikel |
115 |
Refractory anaemia with ring sideroblasts (RAS): Caracterization and prognostic factors
|
Vallespí, T. |
|
1991 |
15 |
S |
p. 18- 1 p. |
artikel |
116 |
Risk adapted therapeutic approaches for CMML
|
|
|
1991 |
15 |
S |
p. 32- 1 p. |
artikel |
117 |
Secondary myelodysplastic syndrome in lymphoproliferative diseases
|
|
|
1991 |
15 |
S |
p. 20- 1 p. |
artikel |
118 |
Serum biochemical parameters are greatly correlated to haematologic findings and may serve as indicators of the proliferative activity in chronic myelomonocytic leukaemia (CMML)
|
|
|
1991 |
15 |
S |
p. 17- 1 p. |
artikel |
119 |
Significance of butyrate-esterase examination for the classification of CMML subtypes
|
|
|
1991 |
15 |
S |
p. 17- 1 p. |
artikel |
120 |
Significance of the responses of patients with myelodysplastic syndromes (MDS) to various treatments
|
|
|
1991 |
15 |
S |
p. 34- 1 p. |
artikel |
121 |
Soluble IL-2 R levels in myelodysplastic syndromes
|
|
|
1991 |
15 |
S |
p. 26- 1 p. |
artikel |
122 |
Survival is related to the reduction of megakaryopoiesis in chronic myelomonocytic leukemia (CMML)
|
Gardais, J. |
|
1991 |
15 |
S |
p. 18- 1 p. |
artikel |
123 |
Tests of rHuEPO administration in patients affected by mielodisplastic syndrome endocrino-metabolic evaluation
|
Savioli, M. |
|
1991 |
15 |
S |
p. 33- 1 p. |
artikel |
124 |
The FGR protein kinase activity in neutrophils of patients with MDS and CML
|
|
|
1991 |
15 |
S |
p. 29- 1 p. |
artikel |
125 |
The reactivities of bone marrow cells with K167, bromodeoxyuridine and GM-CSF MoAbs in childhood MDS
|
Mural Tunčcer, A. |
|
1991 |
15 |
S |
p. 28- 1 p. |
artikel |
126 |
The significance of TDT-positive subpopulations in MDS
|
|
|
1991 |
15 |
S |
p. 31- 1 p. |
artikel |
127 |
The use of immunophenotyping for prediction of early conversion to acute leukemia in myelodysplastic syndromes
|
Mittelman, M. |
|
1991 |
15 |
S |
p. 26- 1 p. |
artikel |
128 |
Transformation in primary myelodysplastic syndromes: Clinical aspects and risk factors
|
Mijović, A |
|
1991 |
15 |
S |
p. 16- 1 p. |
artikel |
129 |
Treatment of myelodysplastic syndromes (MDS) with recombinant human erythropoietin (rHuEPO): Preliminary clinical results
|
Petti, M.C. |
|
1991 |
15 |
S |
p. 33- 1 p. |
artikel |
130 |
Treatment of myelodysplastic syndromes transformed (MDS-T) into AML with the combination of two intercalating agents: Mitoxantrone and daunorubicin plus oncovin (DON)
|
|
|
1991 |
15 |
S |
p. 31- 1 p. |
artikel |
131 |
Treatment of myelodysplastic syndromes with human granulocytic-macrophage colony-stimulating factor (GM-CSF) or GM-CSF combined with low dose (ARA-C)
|
Economopoulos, T. |
|
1991 |
15 |
S |
p. 34- 1 p. |
artikel |
132 |
Trisomy 8 detection in granulomonocytic, erythrocytic and megakaryocytic lineages by CISS hybridization in a case of RARS complicating the course of PNH
|
Parlier, V. |
|
1991 |
15 |
S |
p. 22- 1 p. |
artikel |
133 |
Unexplained macrocytosis in the elderly. A sign of myelodysplasia
|
|
|
1991 |
15 |
S |
p. 19- 1 p. |
artikel |
134 |
Variable patterns of lymphoid involvement in myelodysplastic syndromes (MDS)
|
|
|
1991 |
15 |
S |
p. 25- 1 p. |
artikel |